Mechanistically, hepatic ALDOB inhibits glucose-6-phosphate dehydrogenase (G6PD) activity and the oxidative branch of the PPP by directly binding to G6PD or stabilizing the ALDOB-G6PD-p53 protein complex, thereby reducing glucose consumption and lactate production, and exerting an anti-cancer effect (42). Here, G6PD is linked to cancer.